TEMPORAL MUSCLE THICKNESS AS A PROGNOSTIC MARKER IN A REAL-LIFE COHORT OF NEWLY DIAGNOSED MGMT PROMOTER METHYLATED GLIOBLASTOMA PATIENTS: A MULTICENTRIC IMAGING ANALYSIS

被引：0

作者：

Lazaridis, Lazaros ^{[1
,2
]}

Moenninghoff, Christoph ^{[3
]}

Bumes, Elisabeth ^{[4
]}

Spille, Dorothee Caecilia ^{[5
]}

Muether, Michael ^{[5
]}

Schulz, Tim ^{[6
]}

Heider, Sina ^{[7
]}

Agkatsev, Sarina ^{[1
,2
]}

Schmidt, Teresa

Blau, Tobias ^{[8
]}

Oster, Christoph

Stummer, Walter ^{[1
,2
,5
]}

Kessler, Almuth Friederike ^{[6
]}

Seidel, Clemens ^{[7
]}

Grauer, Oliver ^{[9
]}

Hau, Peter ^{[4
,10
]}

Sure, Ulrich ^{[11
]}

Keyvani, Kathy

Herrlinger, Ulrich ^{[12
,13
]}

Kleinschnitz, Christoph

Stuschke, Martin ^{[14
]}

Herrmann, Ken ^{[15
]}

Deuschl, Cornelius ^{[16
]}

Scheffler, Bjoern ^{[17
]}

Kebir, Sied ^{[1
,2
]}

Glas, Martin ^{[1
,2
]}

机构：

[1] Univ Duisburg Essen, Univ Med Essen, Div Clin Neurooncol, Dept Neurol, Essen, Germany

[2] Univ Duisburg Essen, Univ Med Essen, Div Clin Neurooncol, Ctr Translat Neuro & Behav Sci C TNBS, Essen, Germany

[3] Johannes Wesling Klinikum Minden, Univ Inst Radiol Neuroradiol & Nucl Med, Minden, Germany

[4] Regensburg Univ Hosp, Wilhelm Sander Neurooncol Unit, Regensburg, Germany

[5] Univ Hosp Munster, Dept Neurosurg, Munster, Germany

[6] Univ Hosp Wurzburg, Dept Neurosurg, Wurzburg, Germany

[7] Univ Hosp Leipzig, Dept Radiotherapy & Radiat Oncol, Leipzig, Germany

[8] Univ Duisburg Essen, Univ Med Essen, Inst Neuropathol, Essen, Germany

[9] Univ Hosp Munster, Dept Neurol, Inst Translat Neurol, Munster, Germany

[10] Univ Hosp Regensburg, Dept Neurol, Regensburg, Germany

[11] Univ Duisburg Essen, Univ Med Essen, Dept Neurosurg & Spine Surg, Essen, Germany

[12] Univ Hosp Bonn, Div Clin Neurooncol, Dept Neurol, Bonn, Germany

[13] Univ Hosp Bonn, Ctr Integrated Oncol, Bonn, Germany

[14] Univ Duisburg Essen, Univ Med Essen, Dept Radiotherapy, Essen, Germany

[15] Univ Duisburg Essen, Univ Med Essen, Dept Nucl Med, Essen, Germany

[16] Univ Duisburg Essen, Univ Med Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany

[17] German Canc Res Ctr, Heidelberg, Germany

来源：

NEURO-ONCOLOGY | 2023年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

NIMG-34

引用

页数：2

共 50 条

[21] TEMPORAL MUSCLE THICKNESS IS AN INDEPENDENT PROGNOSTIC MARKER IN PATIENTS WITH PROGRESSIVE GLIOBLASTOMA: TRANSLATIONAL IMAGING ANALYSIS OF THE EORTC-26101 TRIAL
Furtner, J.
Genbrugge, E.
Gorlia, T.
Bendszus, M.
Nowosielski, M.
Golfinopoulos, V.
Weller, M.
van den Bent, M. J.
Wick, W.
Preusser, M.
NEURO-ONCOLOGY, 2019, 21 : 76 - 76
[22] Temporal muscle thickness as an independent prognostic marker in glioblastoma patients—a systematic review and meta-analysis
Nidhisha Sadhwani
Ankita Aggarwal
Ayushi Mishra
Kanwaljeet Garg
Neurosurgical Review, 2022, 45 : 3619 - 3628
[23] Temporal muscle thickness as an independent prognostic marker in glioblastoma patients-a systematic review and meta-analysis
Sadhwani, Nidhisha
Aggarwal, Ankita
Mishra, Ayushi
Garg, Kanwaljeet
NEUROSURGICAL REVIEW, 2022, 45 (06) : 3619 - 3628
[24] Dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging parameters for predicting MGMT promoter methylation and prognostic value in newly diagnosed patients with glioblastoma
Chida, Daiki
Okita, Yoshiko
Utsugi, Reina
Kuroda, Hideki
Hirayama, Ryuichi
Kijima, Noriyuki
Arisawa, Atsuko
Kagawa, Naoki
Kanemura, Yonehiro
Yoshimura, Shinichi
Tomiyama, Noriyuki
Kishima, Haruhiko
ONCOLOGY LETTERS, 2024, 28 (06)
[25] Prognostic assessment in patients with newly diagnosed small cell lung cancer brain metastases: results from a real-life cohort
Steindl, Ariane
Schlieter, Franziska
Klikovits, Thomas
Leber, Elena
Gatterbauer, Brigitte
Frischer, Josa M.
Dieckmann, Karin
Widhalm, Georg
Zoechbauer-Mueller, Sabine
Hoda, Mir Ali Reza
Preusser, Matthias
Berghoff, Anna S.
JOURNAL OF NEURO-ONCOLOGY, 2019, 145 (01) : 85 - 95
[26] Prognostic assessment in patients with newly diagnosed small cell lung cancer brain metastases: results from a real-life cohort
Ariane Steindl
Franziska Schlieter
Thomas Klikovits
Elena Leber
Brigitte Gatterbauer
Josa M. Frischer
Karin Dieckmann
Georg Widhalm
Sabine Zöchbauer-Müller
Mir Ali Reza Hoda
Matthias Preusser
Anna S. Berghoff
Journal of Neuro-Oncology, 2019, 145 : 85 - 95
[27] Prognostic role and interaction of TERT promoter status, telomere length and MGMT promoter methylation in newly diagnosed IDH wild-type glioblastoma patients
Giunco, S.
Padovan, M.
Angelini, C.
Cavallin, F.
Cerretti, G.
Morello, M.
Caccese, M.
Rizzo, B.
d'Avella, D.
Puppa, A. D.
Chioffi, F.
De Bonis, P.
Zagonel, V.
De Rossi, A.
Lombardi, G.
ESMO OPEN, 2023, 8 (03)
[28] INCIDENCE OF TREATMENT-ASSOCIATED IMAGING CHANGES IN NEWLY DIAGNOSED MGMT PROMOTER-METHYLATED GLIOBLASTOMA TREATED WITH CILENGITIDE (EORTC 26071-CENTRIC STUDY): INTERIM ANALYSIS
Flies, C. M.
Friedrich, M.
Lohmann, P.
van Garderen, K.
Smits, M.
Tonn, J. C.
Weller, M.
Galldiks, N.
Snijders, T. J.
NEURO-ONCOLOGY, 2022, 24
[29] A RANDOMIZED PHASE 3 STUDY OF NIVOLUMAB OR PLACEBO COMBINED WITH RADIOTHERAPY PLUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA WITH METHYLATED MGMT PROMOTER: CHECKMATE 548
Weller, Michael
Lim, Michael
Idbaih, Ahmed
Steinbach, Joachim
Finocchiaro, Gaetano
Raval, Raju
Ashby, Lynn
Ansstas, George
Baehring, Joachim
Taylor, Jennie
Honnorat, Jerome
Petrecca, Kevin
De Vos, Filip
Wick, Antje
Sumrall, Ashley
Roberts, Mustimbo
Slepetis, Ruta
Warad, Deepti
Lee, Michelle
Reardon, David
Omuro, Antonio
NEURO-ONCOLOGY, 2021, 23 : 55 - 56
[30] Weak MGMT gene promoter methylation confers a clinically significant survival benefit in patients with newly diagnosed glioblastoma: a retrospective cohort study
Pinson, H.
Hallaert, G.
Van der Meulen, J.
Dedeurwaerdere, F.
Vanhauwaert, D.
Van den Broecke, C.
Van Dorpe, J.
Van Roost, D.
Kalala, J. P.
Boterberg, T.
JOURNAL OF NEURO-ONCOLOGY, 2020, 146 (01) : 55 - 62

← 1 2 3 4 5 →